Al Zaman K, Alhebsi A, Almheiri A, Alhosani H, Alshehhi N, Alwheibi E
Cureus. 2025; 17(1):e77407.
PMID: 39949461
PMC: 11822327.
DOI: 10.7759/cureus.77407.
Al Mawed S, Pankratz V, Chong K, Sandoval M, Roumelioti M, Unruh M
PLoS One. 2018; 13(3):e0194379.
PMID: 29566068
PMC: 5864034.
DOI: 10.1371/journal.pone.0194379.
Aicale R, Tarantino D, Maffulli N
Med Princ Pract. 2017; 26(5):451-455.
PMID: 28810258
PMC: 5757544.
DOI: 10.1159/000480294.
Li B, Fang D, Qian C, Feng H, Wang Y
Clin Drug Investig. 2016; 37(4):327-342.
PMID: 27766511
DOI: 10.1007/s40261-016-0470-3.
Singh A, Kamal R, Mudiam M, Gupta M, Satyanarayana G, Bihari V
PLoS One. 2016; 11(2):e0148641.
PMID: 26871707
PMC: 4752274.
DOI: 10.1371/journal.pone.0148641.
Efficacy of tolvaptan in patients with refractory ascites in a clinical setting.
Ohki T, Sato K, Yamada T, Yamagami M, Ito D, Kawanishi K
World J Hepatol. 2015; 7(12):1685-93.
PMID: 26140088
PMC: 4483550.
DOI: 10.4254/wjh.v7.i12.1685.
Prevalence of hyponatremia in femur neck fractures: a one-year survey in an urban emergency department.
Cervellin G, Mitaritonno M, Pedrazzoni M, Picanza A, Lippi G
Adv Orthop. 2014; 2014:397059.
PMID: 25298896
PMC: 4179951.
DOI: 10.1155/2014/397059.
Tolvaptan.
Rangarajan B, Binoy V, Hingmire S, Noronha V
South Asian J Cancer. 2014; 3(3):182-4.
PMID: 25136528
PMC: 4134612.
DOI: 10.4103/2278-330X.136811.
Paraneoplastic syndromes associated with lung cancer.
Kanaji N, Watanabe N, Kita N, Bandoh S, Tadokoro A, Ishii T
World J Clin Oncol. 2014; 5(3):197-223.
PMID: 25114839
PMC: 4127595.
DOI: 10.5306/wjco.v5.i3.197.
'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting.
Smith C, Robert S
Clin Med (Lond). 2014; 14(4):409-15.
PMID: 25099844
PMC: 4952836.
DOI: 10.7861/clinmedicine.14-4-409.
Management of hyponatremia.
Lee J, Kilonzo K, Nistico A, Yeates K
CMAJ. 2013; 186(8):E281-6.
PMID: 24344146
PMC: 4016091.
DOI: 10.1503/cmaj.120887.
Vaptans: A new option in the management of hyponatremia.
Aditya S, Rattan A
Int J Appl Basic Med Res. 2013; 2(2):77-83.
PMID: 23776817
PMC: 3678699.
DOI: 10.4103/2229-516X.106347.
Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Ost D, Yeung S, Tanoue L, Gould M
Chest. 2013; 143(5 Suppl):e121S-e141S.
PMID: 23649435
PMC: 4694609.
DOI: 10.1378/chest.12-2352.
Pharmacokinetics of intravenous conivaptan in subjects with hepatic or renal impairment.
Roy M, Erdman K, Abeyratne A, Plumb L, Lasseter K, Riff D
Clin Pharmacokinet. 2013; 52(5):385-95.
PMID: 23456393
DOI: 10.1007/s40262-013-0047-8.
Effect of hypokalemia on the clinical impact of hyponatremia.
Hegazi M
J Clin Hypertens (Greenwich). 2012; 14(9):656.
PMID: 22947368
PMC: 8816451.
DOI: 10.1111/j.1751-7176.2012.00643.x.
Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan.
Gaglio P, Marfo K, Chiodo 3rd J
Dig Dis Sci. 2012; 57(11):2774-85.
PMID: 22732834
PMC: 3472061.
DOI: 10.1007/s10620-012-2276-3.